Turn Therapeutics TTRX
NASDAQ TTRX
$9.74 -0.05 (-0.46%)
As of: Nov 10, 2026 · 1:02 PM EST

Turn Therapeutics (TTRX) Enterprise Value (2025 - 2026)

Updated

Turn Therapeutics (TTRX) reported Enterprise Value of $207.16 million for Q2 2026, up 145.7% from the prior quarter.

Analysis

Turn Therapeutics (TTRX) Enterprise Value (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Turn Therapeutics' Enterprise Value came in at $190.56 million; for FY2025, it was $110.94 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Turn Therapeutics 300.41 Mn 273.52 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 207.16 Mn
Mar 31, 2026 84.31 Mn
Dec 31, 2025 110.94 Mn
API Access

Turn Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=TTRX&period=max&api_key=YOUR_API_KEY